| December 2017 |
| 1 Dec |
U.S. FDA Approves Mylan and Biocon´s OgivriTM the First Biosimilar for Trastuzumab, for the Treatment of HER2Positive Breast and Gastric Cancers
|
 |
| November 2017 |
| 23 Nov |
Biocon Launches KRABEVA® Biosimilar Bevacizumab for Treating Several Types of Cancer in India
|
|
| October 2017 |
| 13 Sept |
FDA Issues CRL to Mylan and Biocon's Neulasta Biosimilar
|
|
| September 2017 |
| 20 Sept |
Biocon´s Vishakhapatnam API facility completes US FDA inspection
|
|
| 07 Sept |
Biocon's insulin facility in Malaysia clears inspections for European market
|
|
| August 2017 |
| 31 Aug |
Trastuzumab commercialisation on track, Biocon says after USFDA extends review deadline by 3 months
|
|
| 16 Aug |
#MakeInIndia – Kiran Mazumdar-Shaw
|
|
| July 2017 |
| 31 Jul |
Mazumdar Shaw: We are seeing a recovery in the second quarter |
|
| 21 Jul |
Biocon Featured in ´Outlook Business Outperformers´ special edition
|
|
| 17 Jul |
It's Biocon's day in the sun |
|
| 14 Jul |
Biocon–Mylan´s Breast Cancer Biosimilar Cancer biosimilar gets Thumbs-up from USFDAs Oncologic Drugs Advisiory Committee |
|
| 15 Jul |
US FDA Panel Nod for Biocon Breast Cancer Drug Biosimilar |
|
| May 2017 |
| 8 May |
'We need a system which provides quality drugs at low cost' Interview with Ms. Shaw |
|
| 5 May |
US institute honours Kiran with award for excellence |
|
| April 2017 |
| 28 Apr |
Biocon set to issue bonus shares 2:1; revenue flat in Q4 |
|
| 28 Apr |
Biocon Q4 profits up 75% to Rs 135-Cr |
|
| March 2017 |
| 27 Mar |
Our biologics business is expected to continue on its strong growth trajectory |
|
| 17 Mar |
For Biocon, Windfall seen from drug launch |
|
| 08 Mar |
Biocon’s strong positioning in the area of Biosimilars and robust pipeline. |
|
| 01 Mar |
Healing The World |
|
| February 2017 |
| 16 Feb |
USFDA accepts Biocon's drug application for review |
|
| 02 Feb |
We expect Malaysia unit to break even next year |
|
| January 2017 |
| 31 Jan |
Biocon Limited: Strong quarter, positive trends |
|
| 30 Jan |
Tech based patient tracking to make its debut in state |
|
| 30 Jan |
Biocon aims for the highest quality in the lowest cost |
|
| 27 Jan |
Biocon Q3:all eyes on pot at the end of rainbow |
|
| 26 Jan |
'We expect a turnaround in branded formulations in FY18' |
|
| 26 Jan |
Biocon bags Rs 460-cr contract from Malaysia |
|
| 17 Jan |
In Biocon, investors sees a blockbuster pipeline |
|
| 14 Jan |
Biocon a leading Indian play on global biosimilar scene |
|
| 13 Jan |
Market opportunity for trastuzumab is $7 billion |
|
| 05 Jan |
Biocon has little room to slip up after strong 2016 |
|
| 05 Jan |
These graduates aim to take Biotech to another level |
|
